Serum viral status before and after immunosuppressive therapy
| Patient no. . | HBsAg . | Anti-HBc IgM . | HBeAg . | Anti-HBe . | HBV DNA . | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Before . | After . | Before . | After . | Before . | After . | Before . | After . | Before . | After . | |
| 1 | + | + | − | − | + | − | − | + | + | + |
| 2 | + | + | − | − | − | − | + | + | + | − |
| 3 | + | + | − | − | − | − | + | + | − | − |
| 43-150 | + | NA | − | NA | + | NA | − | NA | + | NA |
| 5 | + | + | − | − | − | − | + | + | + | + |
| 6 | + | − | − | − | + | − | − | + | + | + |
| 7 | + | + | − | − | − | − | + | + | + | + |
| 8 | + | + | − | − | − | − | + | + | − | − |
| 9 | + | − | − | − | − | − | + | + | − | − |
| 10 | + | + | − | − | − | − | + | + | + | + |
| 11 | + | + | − | − | − | − | + | + | − | − |
| 12 | + | + | − | − | − | − | + | + | − | − |
| 13 | + | + | − | − | − | − | + | + | + | − |
| Patient no. . | HBsAg . | Anti-HBc IgM . | HBeAg . | Anti-HBe . | HBV DNA . | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Before . | After . | Before . | After . | Before . | After . | Before . | After . | Before . | After . | |
| 1 | + | + | − | − | + | − | − | + | + | + |
| 2 | + | + | − | − | − | − | + | + | + | − |
| 3 | + | + | − | − | − | − | + | + | − | − |
| 43-150 | + | NA | − | NA | + | NA | − | NA | + | NA |
| 5 | + | + | − | − | − | − | + | + | + | + |
| 6 | + | − | − | − | + | − | − | + | + | + |
| 7 | + | + | − | − | − | − | + | + | + | + |
| 8 | + | + | − | − | − | − | + | + | − | − |
| 9 | + | − | − | − | − | − | + | + | − | − |
| 10 | + | + | − | − | − | − | + | + | + | + |
| 11 | + | + | − | − | − | − | + | + | − | − |
| 12 | + | + | − | − | − | − | + | + | − | − |
| 13 | + | + | − | − | − | − | + | + | + | − |
HBsAg indicates hepatitis B surface antigen; HBc, hepatitis B core; Ig, immunoglobulin; HBeAg, hepatitis Be antigen; HBV, hepatitis C virus; NA, not available.
Patient died before serological data were obtained.